1+ day, 21+ hour ago   (424+ words) Etcamah is a once-daily pill that breaks down the estrogen receptor many breast cancers use to grow and is already approved for a narrower group of breast cancer patients. The setback lands on a pipeline already under scrutiny. Shares of…...

2+ mon, 6+ day ago   (198+ words) Choice Van Line operates as a licensed and insured interstate moving carrier serving residential and commercial customers throughout the continental United States. By working directly with customers from the initial estimate through final delivery, the company focuses on providing consistent…...

9+ mon, 4+ day ago   (497+ words) The new HER2DX central nervous system (CNS) progression score predicts risk of brain progression in advanced HER2+ breast cancer, addressing a major unmet need in identifying patients at the highest risk of CNS involvement. During SABCS 2025, the company presents a total of…...

9+ mon, 4+ week ago   (632+ words) With backing from leading healthcare investors, Clairity accelerates its mission to predict and prevent breast cancer and expand into cardiovascular disease. BOSTON, November 13,... Oops, something went wrong Clairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for…...

10+ mon, 1+ week ago   (312+ words) joni celebrates top 20 national ranking and milestone of one million products donated Founded by Linda Biggs and Jayesh Vekariya, joni has become a leading voice for sustainable and equitable access to period care. The company’s rapid growth has been driven…...

11+ mon, 1+ week ago   (656+ words) NEW YORK, October 02, 2025--Ataraxis AI, a frontier laboratory developing artificial intelligence (AI)–powered prognostic tools for oncology, and MEDSIR (Medica Scientia Innovation Research), a global leader in oncology research, today announced a strategic collaboration to integrate artificial intelligence into multiple…...